News Archives - Roslin CT

FDA approves Omisirge® as First Approved Cell Therapy to Treat Severe Aplastic Anemia

Cell and Gene Therapy, Cell Therapy, cGMP Manufacturing

December 08, 2025

FDA approves Omisirge® as First Approved Cell Therapy to Treat Severe Aplastic Anemia

RoslinCT and Ayrmid Pharma Ltd. Announce Their Intent to Enter Into a Strategic Partnership to Manufacture FDA Approved Cell Therapy Omisirge® (omidubicel-onlv)

Cell and Gene Therapy, Cell Therapy, cGMP Manufacturing, Tech Transfer

March 11, 2025

RoslinCT and Ayrmid Pharma Ltd. Announce Their Intent to Enter Into a Strategic Partnership to Manufacture FDA Approved Cell Therapy Omisirge® (omidubicel-onlv)

RoslinCT Announces Appointment of Jessica Carmen as Chief Commercial Officer

Cell Therapy, Leadership

November 04, 2024

RoslinCT Announces Appointment of Jessica Carmen as Chief Commercial Officer

RoslinCT Wins Manufacturer of the Year at the 9th Massachusetts Manufacturing Awards Ceremony

Cell and Gene Therapy, Cell Therapy

September 30, 2024

RoslinCT Wins Manufacturer of the Year at the 9th Massachusetts Manufacturing Awards Ceremony

RoslinCT Appoints Professor Sir Peter Mathieson and Alexander Vos as New Non-Executive Directors

Cell and Gene Therapy, Cell Therapy, Leadership

June 25, 2024

RoslinCT Appoints Professor Sir Peter Mathieson and Alexander Vos as New Non-Executive Directors

Governor Healey Highlights Life Sciences Investments from Mass Leads Act in Worcester and Hopkinton

Cell and Gene Therapy, Leadership

March 07, 2024

Governor Healey Highlights Life Sciences Investments from Mass Leads Act in Worcester and Hopkinton

RoslinCT to manufacture first-ever US FDA approved CRISPR-based gene therapy CASGEVY™ (exagamglogene autotemcel)

Cell and Gene Therapy, Cell Therapy, cGMP Manufacturing

December 11, 2023

RoslinCT to manufacture first-ever US FDA approved CRISPR-based gene therapy CASGEVY™ (exagamglogene autotemcel)

Ian McCubbin receives Peter Dunnill award at bioProcessUK

Cell and Gene Therapy, Leadership

December 07, 2023

Ian McCubbin receives Peter Dunnill award at bioProcessUK

RoslinCT to manufacture exagamglogene autotemcel (exa-cel) for Vertex Pharmaceuticals Inc following an extensive development collaboration

Cell and Gene Therapy, Cell Therapy, cGMP Manufacturing

November 28, 2023

RoslinCT to manufacture exagamglogene autotemcel (exa-cel) for Vertex Pharmaceuticals Inc following an extensive development collaboration